InCarda Therapeutics Funding: $120M Raised, Series C (2020)
InCarda Therapeutics is based in Boston, MA. It has raised $120M in total funding. Latest round: Series C. Backed by Innoviva.
InCarda Therapeutics funding overview
InCarda Therapeutics is based in Boston, MA. InCarda Therapeutics has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in October 2020. The round record for InCarda Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Innoviva.
InCarda Therapeutics at a glance
Total raised
$120M
Latest round
Series C
Latest round date
October 2020
Headquarters
Boston, MA
Notable investors
Innoviva
Frequently asked about InCarda Therapeutics funding
How much has InCarda Therapeutics raised?
InCarda Therapeutics has raised $120M in total disclosed funding across the rounds on record.
Who has invested in InCarda Therapeutics?
Innoviva are named among the investors backing InCarda Therapeutics.
What was the latest InCarda Therapeutics funding round?
The most recent disclosed round is a Series C, announced in October 2020.
Where is InCarda Therapeutics based?
InCarda Therapeutics is based in Boston, MA.
When did InCarda Therapeutics last raise?
The last disclosed InCarda Therapeutics round closed in October 2020 at Series C.
Round data for InCarda Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boston and backer lists below.
